# Planchez,-B.,-Surget,-A.,-&-Belzung,-C.-(2019).-Animal-models-of-major-depression-Drawbacks-and-cha

## **SkellyBot**:

 [message link](https://discord.com/channels/1194766712680222800/1219829931450699816/1219830086166118431) 

 # Planchez et al. (2019) - Animal models of depression challenges
## Title
The title of the research article is "Animal models of major depression: Drawbacks and challenges."

## Citation:
Planchez, B., Surget, A., & Belzung, C. (2019). Animal models of major depression: Drawbacks and challenges. Journal of Neural Transmission (Vienna, Austria: 1996), 126(11), 1383–1408. https://doi.org/10.1007/s00702-019-02084-y

## Basic Methodology
MORE INFORMATION NEEDED

## Detailed Summary
- **[[Animal Models]]**: Current models involve environmental manipulation or biological underpinnings like gene alteration or targeted brain lesions.
  - These manipulations result in behavioral and biological changes relevant to depression symptoms and pathophysiology.
- **Model Shortcomings**: Significant drawbacks of animal models lead to stagnation in innovative pharmacological treatments for depression.
  - Limitations in these models also restrict the study of treatment-resistant depression.
- **Model Evolution**: Discussion on the validity of these models, treatment-resistant depression, major depression subtypes, and recurrent depression.
  - Proposes new approaches focusing on dimensions of depression rather than categorical types.

## Paper summaries
### Short Summary
The paper reviews the current animal models for major depression, highlighting their limitations and the need for new paradigms to address treatment-resistant and recurrent depression.

### Very Short Summary
Reveals the shortcomings of animal models in depression research.

### Extremely Short Summary
Challenges in animal depression models.

### Tags
#animal-models #major-depression #research-challenges #treatment-resistant-depression #recurrent-depression #depression-pathophysiology #pharmacological-treatments

## **cassidy.jones**:

 [message link](https://discord.com/channels/1194766712680222800/1219829931450699816/1219830079417225246) 

 ```
Using the text in this conversation, please come up with a document following the schema (at the bottom) which contains sections described below. Wrap [[key terms]] in double brackets to create wiki style links: 

BEGIN SECTION DESCRIPTIONS:

title:  "The title of the research article"
author_year:  "The author and year of the research article (e.g. 'Smith et al. 2020')"
citation:  "The citation to the research article"

detailed_summary:  "A detailed summary/overview of the major points of the paper in a bulleted outline format with 1-2 sentence top level bullet points and second-level bullet points"
short_summary:  "A short (2-3 sentence) summary of the paper"
very_short_summary:  "A very short one sentence summary of the research article"
extremely_short_summary:  "An extremely short 6-10 word summary of the research article"
basic_methodology: "A basic description of the methodology used in the research article (e.g. information about tools used, species studied, analytical techniques, etc.)"
summary_title:      "A summary title made by combining the `author_year` field with the `extremely_short_summary` field, like this: ['author_year'] - ['extremely_short_summary']")
tags:  "A list of tags formatted using #kebab-case-lowercase")

END SECTION DESCRIPTIONS

BEGIN DOCUMENT SCHEMA EXAMPLE:
# {summary_title}\n
## Title\n
{title}\n\n
## Citation:\n
{citation}\n\n
## Basic Methodology\n
{basic_methodology}\n\n
## Detailed Summary\n
{detailed_summary}\n\n
## Paper summaries
### Short Summary\n
{short_summary}\n\n
### Very Short Summary\n
{very_short_summary}\n\n
### Extremely Short Summary\n
{extremely_short_summary}\n\n

### Tags\n
{tags}\n\n

END DOCUMENT SCHEMA EXAMPLE


DO NOT MAKE THINGS UP! If you do not have enough information to complete your task, just put `MORE INFORMATION NEEDED` in that section and then ask the human to provide the necessary information.
```

## **SkellyBot**:

 [message link](https://discord.com/channels/1194766712680222800/1219829931450699816/1219830032566845632) 

 This summary highlights the critical necessity for valid animal models to advance the understanding and treatment of major depression and its complexities, such as treatment resistance and chronicity. The paper discusses various methods of modeling, including environmental manipulation and biological underpinnings, and acknowledges the substantial limitations that these models present.

**Reflective Questions for Your Capstone:**

- **Relevance to Human Depression**: How might the findings from animal models be cautiously interpreted to apply to human neuropsychiatric conditions, considering the symptomatic and pathophysiological differences?
- **Innovation in Pharmacology**: Given the limitations in translating animal model research to innovative human treatments, how could your research into gene expression and BDNF contribute to this field?
- **Dimensional Approaches**: How might a dimensional approach to depression, as opposed to a categorical one, influence the direction of your capstone project, especially when considering the role of exercise in neuropsychiatric health?

As you continue to build your capstone project, integrating these considerations can help frame your research questions and methodology. It's also important to think about how these models could potentially inform the intersection of exercise, epigenetics, and neuropsychiatric conditions.

Feel free to share any thoughts or questions you have based on this paper, or let me know if there's a specific direction you'd like to take this discussion that would support your project goals.

## **cassidy.jones**:

 [message link](https://discord.com/channels/1194766712680222800/1219829931450699816/1219830031078002689) 

 Major depression is a leading contributor to the global burden of disease. This situation is mainly related to the chronicity and/or recurrence of the disorder, and to poor response to antidepressant therapy. Progress in this area requires valid animal models. Current models are based either on manipulating the environment to which rodents are exposed (during the developmental period or adulthood) or biological underpinnings (i.e. gene deletion or overexpression of candidate genes, targeted lesions of brain areas, optogenetic control of specific neuronal populations, etc.). These manipulations can alter specific behavioural and biological outcomes that can be related to different symptomatic and pathophysiological dimensions of major depression. However, animal models of major depression display substantial shortcomings that contribute to the lack of innovative pharmacological approaches in recent decades and which hamper our capabilities to investigate treatment-resistant depression. Here, we discuss the validity of these models, review putative models of treatment-resistant depression, major depression subtypes and recurrent depression. Furthermore, we identify future challenges regarding new paradigms such as those proposing dimensional rather than categorical approaches to depression.

## **SkellyBot**:

 [message link](https://discord.com/channels/1194766712680222800/1219829931450699816/1219829938639732819) 

 It sounds like you're delving into the research on animal models related to major depression, which is a critical area when considering neuropsychiatric disorders. This particular paper appears to discuss the limitations and obstacles faced when using animal models to study major depression. Understanding these challenges is essential for interpreting research findings and considering how they may translate to human conditions.

As you explore this paper and topic, consider the following:

- **Comparative Analysis**: How do the models discussed compare to human depression in terms of symptomatology and underlying biological mechanisms?
- **Model Limitations**: What specific drawbacks does the paper highlight about the current animal models used for major depression?
- **Research Implications**: How might these limitations affect the development of therapeutics and our understanding of the pathophysiology of depression?

Remember to take detailed notes on these aspects as they can greatly inform your capstone project, particularly when considering the impact of exercise on neuropsychiatric conditions. If you have any specific questions or insights from this paper that you'd like to discuss further, feel free to share.

## **SkellyBot**:

 [message link](https://discord.com/channels/1194766712680222800/1219829931450699816/1219829933954699356) 

 Starting new chat with initial message:

> Planchez, B., Surget, A., & Belzung, C. (2019). Animal models of major depression: Drawbacks and challenges. Journal of Neural Transmission (Vienna, Austria: 1996), 126(11), 1383–1408. https://doi.org/10.1007/s00702-019-02084-y

![chat-1219829931450699816.json](https://cdn.discordapp.com/attachments/1219829931450699816/1219830182299570216/chat-1219829931450699816.json?ex=6615f4e2&is=66037fe2&hm=c5693bbe20c0414262ff3d4ffbc30ebed718458edcd4323e7e5172ce7ed22bbb&)

## **SkellyBot**:

 [message link](https://discord.com/channels/1194766712680222800/1219829931450699816/1219829932486688908) 

 

